Cancer

Title
Study Comparing Standard Radiation Therapy Treatment to an Investigational Treatment of Radiation Therapy Combined with Chemotherapy in Patients with Cervical Cancer
Trial Number
202836072110
Number of Participants
480
Principal Investigator
Eligibility

Participants may be eligible if they have pathologically proven primary cervical cancer I/IIA with squamous cell carcinoma, adenosquamous carcinoma or adenocarcinoma initially treated with a standard radical hysterectomy with pelvic lymphadenectomy. Additional requirements are in the protocol.

Purpose

The purpose of this study is to determine if the investigational treatment is better than the standard treatment.

Enrollment

(708) 327-3222

MORE CLINICAL TRIALS

Clinical Trials

For more information call (888) LUHS-888.